GSK (LON:GSK) Earns Buy Rating from Jefferies Financial Group

Jefferies Financial Group reissued their buy rating on shares of GSK (LON:GSK) in a research note issued to investors on Thursday morning, Marketbeat reports. They currently have a GBX 2,100 ($26.64) target price on the stock.

Other equities analysts have also issued reports about the stock. Shore Capital reiterated a buy rating on shares of GSK in a report on Wednesday, June 12th. Deutsche Bank Aktiengesellschaft reiterated a buy rating and set a GBX 1,950 ($24.74) price objective on shares of GSK in a research note on Tuesday, June 18th. Citigroup reissued a buy rating and issued a GBX 2,100 ($26.64) target price on shares of GSK in a research note on Monday, June 24th. Barclays reaffirmed an equal weight rating and issued a GBX 1,725 ($21.88) price target on shares of GSK in a research report on Tuesday, May 7th. Finally, JPMorgan Chase & Co. reissued an underweight rating on shares of GSK in a research report on Tuesday, June 18th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of Moderate Buy and a consensus price target of GBX 1,791.25 ($22.72).

GSK Stock Up 0.2 %

Shares of GSK stock opened at GBX 1,529.50 ($19.40) on Thursday. GSK has a 1 year low of GBX 1,302.60 ($16.52) and a 1 year high of GBX 1,823.50 ($23.13). The firm has a market cap of £62.40 billion, a price-to-earnings ratio of 1,403.21, a PEG ratio of 1.19 and a beta of 0.27. The company has a 50-day moving average of GBX 1,685.84 and a 200 day moving average of GBX 1,632.29. The company has a debt-to-equity ratio of 134.34, a current ratio of 0.87 and a quick ratio of 0.73.

GSK Cuts Dividend

The business also recently announced a dividend, which will be paid on Thursday, July 11th. Shareholders of record on Thursday, May 16th will be paid a dividend of GBX 15 ($0.19) per share. This represents a yield of 0.9%. The ex-dividend date of this dividend is Thursday, May 16th. GSK’s dividend payout ratio is currently 5,504.59%.

Insider Activity

In related news, insider Wendy Becker acquired 446 shares of the firm’s stock in a transaction dated Thursday, June 20th. The stock was purchased at an average cost of GBX 1,614 ($20.47) per share, with a total value of £7,198.44 ($9,131.60). Insiders own 1.60% of the company’s stock.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.